| Impact of in vitro SARS-CoV-2 infection on breast cancer cells M Sommariva, M Dolci, T Triulzi, F Ambrogi, M Dugo, L De Cecco, ... Scientific Reports 14 (1), 13134, 2024 | | 2024 |
| 47MO The risk index of early relapse defined by MiROvaR, a miRNA-based classifier, is a potential predictive marker for bevacizumab benefit: A MITO-MANGO-ENGOT study M Bagnoli, L De Cecco, D Califano, D Russo, A Spina, I Dipaola, ... ESMO Open 9, 2024 | | 2024 |
| DIPG-04. THE BENEFIT OF CRANIOSPINAL IRRADIATION (CSI) RESCUE IN PHASE 2 RANDOMIZED STUDY OF RADIOTHERAPY (RT), CONCOMITANT NIMOTUZUMAB AND VINORELBINE AND RE-IRRADIATION AT … M Massimino, V Biassoni, A Mastronuzzi, E Schiavello, F Barretta, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| MDB-04. LONG-TERM OUTCOME OF THE MILANO STRATEGY FOR HIGH-RISK MEDULLOBLASTOMA, INCLUDING THE IMPACT OF MOLECULAR SUBTYPE M Massimino, C Dossena, F Minasi, F Barretta, FR Buttarelli, V Biassoni, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| BIOM-05. THE GUT-MICROBIOTA COMPOSITION IN PEDIATRIC BRAIN TUMORS: AN EMERGING CRUCIAL PLAYER C Dossena, L Bergamaschi, F Rossignoli, AG Licata, M Oriani, M Marra, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| MDB-03. MEDULLOBLASTOMA AT RELAPSE: FOR WHICH PATIENTS AND WHICH TUMORS REIRRADIATION IS THE BETTER CHOICE M Massimino, S Vennarini, FR Buttarelli, M Antonelli, S Minasi, E Pecori, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| SAA1‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness I Rybinska, N Mangano, SL Romero‐Cordoba, V Regondi, V Ciravolo, ... International journal of cancer 154 (10), 1842-1856, 2024 | 2 | 2024 |
| Abstract PO4-14-08: A gene expression-based classifier for HER2-low breast cancer SD Cosimo, S Pizzamiglio, CM Ciniselli, V Duroni, V Cappelletti, ... Cancer Research 84 (9_Supplement), PO4-14-08-PO4-14-08, 2024 | | 2024 |
| Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO S Pizzamiglio, CM Ciniselli, E de Azambuja, D Agbor-Tarh, ... Breast cancer research and treatment, 1-10, 2024 | 1 | 2024 |
| Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study. R Miceli, H Eriksson, L Russo, S Alfieri, F Pietrantonio, L De Cecco, ... Acta Oncologica (Stockholm, Sweden) 63, 213-219, 2024 | | 2024 |
| 187 Transcriptomic and tumor microenvironment landscape of Epstein-Barr virus related Nasopharyngeal Carcinoma in endemic and non-endemic areas. D Lenoci, C Resteghini, MS Serafini, F Pistore, B Ma, S Cavalieri, ... Radiotherapy and Oncology 192, S220-S223, 2024 | | 2024 |
| Insights into HER2-Low Status and the Breast Cancer Immune Microenvironment: A 20-Gene Signature Study S Di Cosimo, S Pizzamiglio, CM Ciniselli, V Duroni, A Blanda, ... European Journal of Cancer 200, 2024 | | 2024 |
| Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities D Lenoci, C Resteghini, MS Serafini, F Pistore, S Canevari, B Ma, ... Translational Research 265, 1-16, 2024 | | 2024 |
| A gene expression-based classifier for HER2-low breast cancer S Di Cosimo, S Pizzamiglio, CM Ciniselli, V Duroni, V Cappelletti, ... Scientific Reports 14 (1), 2628, 2024 | | 2024 |
| Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial S Cavalieri, E Bruno, MS Serafini, D Lenoci, S Canevari, L Lopez-Perez, ... Frontiers in Oncology 13, 1321174, 2024 | | 2024 |
| Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab MS Serafini, S Cavalieri, L Licitra, F Pistore, D Lenoci, S Canevari, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | | 2024 |
| Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case V Vallacchi, E Vergani, M Cossa, C Gargiuli, A Busico, A Devecchi, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 2 | 2024 |
| HeNeCOn: An ontology for integrative research in Head and Neck cancer L Hernández, E Estévez-Priego, L López-Pérez, MF Cabrera-Umpiérrez, ... International Journal of Medical Informatics 181, 105284, 2024 | 2 | 2024 |
| Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens A Ricci, M Dugo, ME Pisanu, L De Cecco, F Raspagliesi, B Valeri, ... Journal of Proteome Research 23 (1), 483-493, 2023 | | 2023 |
| Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors E Minna, A Devecchi, F Pistore, B Paolini, G Mauro, DA Penso, ... Frontiers in Endocrinology 14, 1267499, 2023 | 2 | 2023 |
